564 related articles for article (PubMed ID: 27911277)
21. Glutathione S-transferase T1 polymorphism contributes to bladder cancer risk: a meta-analysis involving 50 studies.
Gong M; Dong W; An R
DNA Cell Biol; 2012 Jul; 31(7):1187-97. PubMed ID: 22339266
[TBL] [Abstract][Full Text] [Related]
22. CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population.
Berber U; Yilmaz I; Yilmaz O; Haholu A; Kucukodaci Z; Ates F; Demirel D
Asian Pac J Cancer Prev; 2013; 14(6):3925-9. PubMed ID: 23886208
[TBL] [Abstract][Full Text] [Related]
23. Glutathione S-Transferase M1 and T1 polymorphisms and hypertension risk: an updated meta-analysis.
Rong SL; Zhou XD; Wang ZK; Wang XL; Wang YC; Xue CS; Li B
J Hum Hypertens; 2019 Jun; 33(6):454-465. PubMed ID: 30420646
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies.
Gong M; Dong W; Shi Z; Xu Y; Ni W; An R
PLoS One; 2012; 7(11):e50587. PubMed ID: 23189206
[TBL] [Abstract][Full Text] [Related]
25. Glutathione S-transferase M1 and T1 polymorphisms and cervical cancer risk: a meta-analysis.
Wang D; Wang B; Zhai JX; Liu DW; Sun GG
Neoplasma; 2011; 58(4):352-9. PubMed ID: 21520994
[TBL] [Abstract][Full Text] [Related]
26. Null genotypes of GSTM1 and GSTT1 contribute to increased risk of diabetes mellitus: a meta-analysis.
Zhang J; Liu H; Yan H; Huang G; Wang B
Gene; 2013 Apr; 518(2):405-11. PubMed ID: 23296061
[TBL] [Abstract][Full Text] [Related]
27. Association of GST genetic polymorphisms with the susceptibility to hepatocellular carcinoma (HCC) in Chinese population evaluated by an updated systematic meta-analysis.
Liu K; Zhang L; Lin X; Chen L; Shi H; Magaye R; Zou B; Zhao J
PLoS One; 2013; 8(2):e57043. PubMed ID: 23437305
[TBL] [Abstract][Full Text] [Related]
28. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder.
Kempkes M; Golka K; Reich S; Reckwitz T; Bolt HM
Arch Toxicol; 1996; 71(1-2):123-6. PubMed ID: 9010594
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India.
Srivastava DS; Kumar A; Mittal B; Mittal RD
Arch Toxicol; 2004 Aug; 78(8):430-4. PubMed ID: 15057507
[TBL] [Abstract][Full Text] [Related]
30. Genetic Polymorphism of GSTM1 and GSTT1 and Risk of Prostatic Carcinoma - a Meta-analysis of 7,281 Prostate Cancer Cases and 9,082 Healthy Controls.
Malik SS; Kazmi Z; Fatima I; Shabbir R; Perveen S; Masood N
Asian Pac J Cancer Prev; 2016; 17(5):2629-35. PubMed ID: 27268642
[TBL] [Abstract][Full Text] [Related]
31. GSTT1 and GSTM1 polymorphisms predict treatment outcome for breast cancer: a systematic review and meta-analysis.
Hu XY; Huang XY; Ma J; Zuo Y; Luo NB; Lai SL; Su DK
Tumour Biol; 2016 Jan; 37(1):151-62. PubMed ID: 26577857
[TBL] [Abstract][Full Text] [Related]
32. Are glutathione S-transferase polymorphisms (GSTM1, GSTT1) associated with primary open angle glaucoma? A meta-analysis.
Lu Y; Shi Y; Yin J; Huang Z
Gene; 2013 Sep; 527(1):311-5. PubMed ID: 23827458
[TBL] [Abstract][Full Text] [Related]
33. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis.
Wang B; Huang G; Wang D; Li A; Xu Z; Dong R; Zhang D; Zhou W
J Hepatol; 2010 Sep; 53(3):508-18. PubMed ID: 20561699
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of the association between GSTM1 and GSTT1 gene polymorphisms and cervical cancer.
Zhang ZY; Jin XY; Wu R; Wu LN; Xing R; Yang SJ; Xie Y
Asian Pac J Cancer Prev; 2012; 13(3):815-9. PubMed ID: 22631654
[TBL] [Abstract][Full Text] [Related]
35. The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer.
Salagovic J; Kalina I; Habalová V; Hrivnák M; Valanský L; Biros E
Physiol Res; 1999; 48(6):465-71. PubMed ID: 10783912
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India.
Sobti RC; Al-Badran AI; Sharma S; Sharma SK; Krishan A; Mohan H
Cancer Genet Cytogenet; 2005 Jan; 156(1):68-73. PubMed ID: 15588859
[TBL] [Abstract][Full Text] [Related]
37. Relationship between GSTM1/GSTT1 null genotypes and renal cell carcinoma risk: a meta-analysis.
Cheng HY; You HY; Zhou TB
Ren Fail; 2012; 34(8):1052-7. PubMed ID: 22880812
[TBL] [Abstract][Full Text] [Related]
38. The GSTM1 and GSTT1 Null Genotypes Increase the Risk for Type 2 Diabetes Mellitus and the Subsequent Development of Diabetic Complications: A Meta-analysis.
Nath S; Das S; Bhowmik A; Ghosh SK; Choudhury Y
Curr Diabetes Rev; 2019; 15(1):31-43. PubMed ID: 29243583
[TBL] [Abstract][Full Text] [Related]
39. Associations of GSTM1 and GSTT1 polymorphisms with pancreatic cancer risk: evidence from a meta-analysis.
Fan Y; Zhang W; Shi CY; Cai DF
Tumour Biol; 2013 Apr; 34(2):705-12. PubMed ID: 23184765
[TBL] [Abstract][Full Text] [Related]
40. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) null polymorphisms and the risk of hypertension: a meta-analysis.
Ge B; Song Y; Zhang Y; Liu X; Wen Y; Guo X
PLoS One; 2015; 10(3):e0118897. PubMed ID: 25742618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
